首页 > 最新文献

Pediatriya - Zhurnal im G.N. Speranskogo最新文献

英文 中文
ENCRUSTING CYSTITIS IN CHILDREN: BIBLIOGRAPHICAL REVIEW AND A CLINICAL CASE 儿童包覆性膀胱炎:文献回顾及一例临床病例
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-204-209
S. S. Nikitin, N. B. Guseva, R. Ignatiev, V. Nikitin
Encrusting cystitis (EC) is not a rare condition in a pediatric urologist’s practice in which layers of precipitated salts form on the inflamed mucosa. It is believed that urease-producing microorganisms are responsible for the development of this disease, of which the most important is Corynebacterium urealiticum. The pathogenicity factors in this bacterium determine its ability to form biofilms, invade the mucous membrane and alkalinize urine. Intensely turbid urine with an ammonia smell can serve as a hallmark for EC despite dysuric phenomena only, which in its turn is the most often characteristic of all cystitis, is the clinical picture for EC. Thus, in urinalysis the attention should be paid to alkaline pH, crystalluria, hematuria and leukocyturia. The most reliable way to diagnose EC is to visualize crystalline deposits against the background of edematous and hyperemic mucosa during cystoscopy, some changes can also be seen on CT and ultrasound of the urinary system. Treatment of EC cystitis is complicated by multiresistance of the Corynebacterium urealiticum, which determines the need for the selection of therapy based on urine culture with the determination of sensitivity to antibiotics. Scientifically observed EC reports in children are extremely rare. Authors therefore offer a description of their own clinical case: a 9-year-old boy was hospitalized twice at the I.N. Grigovich Children's Republican Hospital of the Republic of Karelia (Petrozavodsk, Republic of Karelia, Russia); the first hospitalization was a month after a suffered SARS-CoV-2 infection with subfebrile condition and dysuric manifestations. Bullous cystitis was diagnosed. With positive dynamics against the background of standard therapy, the patient was discharged. Then, 4 days after the discharge, dysuric phenomena had reappeared with temperature rises, first to subfebrile and then to febrile values. A month after the first discharge, the patient had been readmitted again. EC was revealed, electroexcision of the mucosa with encrustations was performed. The result of the treatment was the recovery.
在儿科泌尿科医生的实践中,结痂性膀胱炎(EC)并不是一种罕见的情况,在炎症粘膜上形成沉淀盐层。人们认为,产生脲酶的微生物是导致这种疾病的原因,其中最重要的是脲棒状杆菌。这种细菌的致病性因素决定了它形成生物膜、侵入粘膜和碱化尿液的能力。强烈浑浊的尿液带有氨气气味,可以作为EC的标志,尽管只有排尿困难的现象,而排尿困难是所有膀胱炎最常见的特征,是EC的临床表现。因此,在尿液分析中应注意碱性pH值、结晶尿、血尿和白细胞尿。诊断EC最可靠的方法是在膀胱镜检查时,在水肿和充血的粘膜背景下观察结晶沉积,也可以在CT和泌尿系统超声上看到一些变化。EC膀胱炎的治疗因尿道棒状杆菌的多重耐药而复杂化,这决定了需要根据尿液培养和抗生素敏感性的测定来选择治疗方法。科学观察到的儿童EC报告极为罕见。因此,提交人描述了他们自己的临床病例:一名9岁男孩在卡累利阿共和国I.N.格里戈维奇儿童共和国医院(俄罗斯卡累利阿共和国彼得罗扎沃茨克)住院两次;第一次住院是在感染SARS-CoV-2后一个月,出现低热和尿痛症状。诊断为大疱性膀胱炎。在标准治疗的背景下,在积极的动力下,患者出院。出院后第4天,再次出现发热现象,体温升高,先降至亚热,再降至热值。第一次出院一个月后,患者再次入院。发现EC,电切有结痂的粘膜。治疗的结果是康复。
{"title":"ENCRUSTING CYSTITIS IN CHILDREN: BIBLIOGRAPHICAL REVIEW AND A CLINICAL CASE","authors":"S. S. Nikitin, N. B. Guseva, R. Ignatiev, V. Nikitin","doi":"10.24110/0031-403x-2023-102-4-204-209","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-204-209","url":null,"abstract":"Encrusting cystitis (EC) is not a rare condition in a pediatric urologist’s practice in which layers of precipitated salts form on the inflamed mucosa. It is believed that urease-producing microorganisms are responsible for the development of this disease, of which the most important is Corynebacterium urealiticum. The pathogenicity factors in this bacterium determine its ability to form biofilms, invade the mucous membrane and alkalinize urine. Intensely turbid urine with an ammonia smell can serve as a hallmark for EC despite dysuric phenomena only, which in its turn is the most often characteristic of all cystitis, is the clinical picture for EC. Thus, in urinalysis the attention should be paid to alkaline pH, crystalluria, hematuria and leukocyturia. The most reliable way to diagnose EC is to visualize crystalline deposits against the background of edematous and hyperemic mucosa during cystoscopy, some changes can also be seen on CT and ultrasound of the urinary system. Treatment of EC cystitis is complicated by multiresistance of the Corynebacterium urealiticum, which determines the need for the selection of therapy based on urine culture with the determination of sensitivity to antibiotics. Scientifically observed EC reports in children are extremely rare. Authors therefore offer a description of their own clinical case: a 9-year-old boy was hospitalized twice at the I.N. Grigovich Children's Republican Hospital of the Republic of Karelia (Petrozavodsk, Republic of Karelia, Russia); the first hospitalization was a month after a suffered SARS-CoV-2 infection with subfebrile condition and dysuric manifestations. Bullous cystitis was diagnosed. With positive dynamics against the background of standard therapy, the patient was discharged. Then, 4 days after the discharge, dysuric phenomena had reappeared with temperature rises, first to subfebrile and then to febrile values. A month after the first discharge, the patient had been readmitted again. EC was revealed, electroexcision of the mucosa with encrustations was performed. The result of the treatment was the recovery.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73684325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRIMARY HYPERPARATHYROIDISM AS A CAUSE OF NEPHROCALCINOSIS AND NEPHROLITHIASIS IN AN ADOLESCENT PATIENT: A CLINICAL CASE
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-186-193
E. Orekhova, O. Chugunova, S. Blokh, M. Boyadjan, M. Yudin, P.V. Pavlova, O. I. Yaroshevskaya, P. Shumilov
Article describes a clinical case of a female adolescent with macrohematuria, nephrocalcinosis, nephrolithiasis and cholelithiasis, in which laboratory examination and imaging of parathyroid glands gave grounds to diagnose primary hyperparathyroidism due to parathyroid adenoma. Diagnosis was based on laboratory examination and later confirmed by instrumental methods: when hypercalcemia was detected, the necessary determination of parathyroid hormone level took place and when it increased, a mandatory biochemical analysis of urine was performed as well as required. Despite the rarity of primary hyperparathyroidism in childhood, alertness in relation to this pathology is necessary for pediatric practitioners of various specialties, including pediatric physicians and nephrologists, since this pathology is more likely in cases of nephrocalcinosis, nephrolithiasis and urolithiasis in children.
本文报告一女性青少年大量血尿、肾钙质沉着症、肾结石和胆石症的临床病例,其中甲状旁腺的实验室检查和影像学检查为诊断甲状旁腺腺瘤引起的原发性甲状旁腺功能亢进提供了依据。诊断基于实验室检查,后来通过仪器方法证实:当检测到高钙血症时,进行必要的甲状旁腺激素水平测定,当它升高时,强制进行尿液生化分析。尽管原发性甲状旁腺功能亢进症在儿童中很少见,但对于各种专业的儿科医生,包括儿科医生和肾病学家来说,警惕这种病理是必要的,因为这种病理更可能出现在儿童肾钙质沉着症、肾结石和尿石症的病例中。
{"title":"PRIMARY HYPERPARATHYROIDISM AS A CAUSE OF NEPHROCALCINOSIS AND NEPHROLITHIASIS IN AN ADOLESCENT PATIENT: A CLINICAL CASE","authors":"E. Orekhova, O. Chugunova, S. Blokh, M. Boyadjan, M. Yudin, P.V. Pavlova, O. I. Yaroshevskaya, P. Shumilov","doi":"10.24110/0031-403x-2023-102-4-186-193","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-186-193","url":null,"abstract":"Article describes a clinical case of a female adolescent with macrohematuria, nephrocalcinosis, nephrolithiasis and cholelithiasis, in which laboratory examination and imaging of parathyroid glands gave grounds to diagnose primary hyperparathyroidism due to parathyroid adenoma. Diagnosis was based on laboratory examination and later confirmed by instrumental methods: when hypercalcemia was detected, the necessary determination of parathyroid hormone level took place and when it increased, a mandatory biochemical analysis of urine was performed as well as required. Despite the rarity of primary hyperparathyroidism in childhood, alertness in relation to this pathology is necessary for pediatric practitioners of various specialties, including pediatric physicians and nephrologists, since this pathology is more likely in cases of nephrocalcinosis, nephrolithiasis and urolithiasis in children.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77521949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SYSTEMATIC BIBLIOGRAPHICAL REVIEW AND META-ANALYSIS OF THORACOSCOPIC VS. OPEN-SURGICAL TREATMENT OF ESOPHAGEAL ATRESIA 胸腔镜与开放手术治疗食管闭锁的系统文献回顾和meta分析
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-112-124
Y. Kozlov, S. Poloyan, A. A. Marchuk, A. Rozhanski, A. A. Byrgazov, K. Kovalkov, C. Ochirov, V. Kapuller, A. Narkevich
Thoracoscopic reconstruction of esophageal atresia (EA) has become a standard procedure in many surgical centers Worldwide. The existing bibliographical reviews and meta-analyses have failed to demonstrate any significant difference in the immediate outcome of mini-aggressive treatment of EA. Authors had performed this truly systematic review and meta-analysis searching for the new evidence and confirmation of success of thoracoscopy in the treatment of EA. Materials and methods used: the systematic bibliographical review was prepared in accordance with the PRISMA 2020 statement guidelines. Thus, the scientific publications starting 1990 were searched in three major databases as follows: MEDLINE, PubMed and eLIBRARY.RU. Results: the included studies were published between 2008 and 2022 representing a total of 1958 cases that included 1369 (69.92%) open-surgery interventions and 589 (30.08%) thoracoscopic ones. Authors have found no significant difference between thoracoscopy and thoracotomy excluding an increased risk for esophageal anastomotic leak in the open-surgery treatment group (OR, 0.68; 95% CI, 0.46; 0.99; p = 0.04). A meta-analysis demonstrated that the thoracoscopy group had shorter time spent on lung ventilation (MD, -1.83; 95% CI, -3.02; -0.63; p = 0.003), shorter period to start oral feeding (MD, -1.34; 95% CI, -2.13; -0.56; p = 0.0008) and shorter hospital stay (MD, -4.26; 95% CI, -7.03; -1.49; p = 0.003). The data on the long-term outcomes of both thoracoscopic and open-surgery interventions were reported in a limited - insufficient number of observed cases and had demonstrated that gastroesophageal reflux was more common in the thoracoscopy group (OR, 2.82; 95% CI, 1.72; 4.61; p < 0.0001). Conclusion: the meta-analysis had proved that, compared to open-surgery, thoracoscopy is associated with an almost comparable rate of postoperative complications coupled with the exception of anastomotic leaks. However, it is impossible to ignore the significant advantages of the modern method for treatment of EA which is characterized - among other things - by the more rapid recovery of patients after the surgical interventions.
胸腔镜下食管闭锁(EA)重建已成为世界上许多外科中心的标准手术。现有的文献综述和荟萃分析未能证明微创治疗EA的直接结果有任何显著差异。作者进行了这项真正的系统综述和荟萃分析,以寻找胸腔镜治疗EA成功的新证据和确认。使用的材料和方法:系统文献综述是根据PRISMA 2020声明指南准备的。因此,在以下三个主要数据库中检索了1990年以来的科学出版物:MEDLINE、PubMed和eLIBRARY.RU。结果:纳入的研究发表于2008年至2022年,共涉及1958例病例,其中包括1369例(69.92%)开放手术干预和589例(30.08%)胸腔镜干预。作者发现,除开放手术组食管吻合口漏的风险增加外,胸腔镜和开胸手术没有显著差异(OR, 0.68;95% ci, 0.46;0.99;p = 0.04)。一项荟萃分析显示,胸腔镜组肺通气时间较短(MD, -1.83;95% ci, -3.02;-0.63;p = 0.003),开始口服喂养时间较短(MD, -1.34;95% ci, -2.13;-0.56;p = 0.0008)和更短的住院时间(MD, -4.26;95% ci, -7.03;-1.49;p = 0.003)。关于胸腔镜和开腹手术干预的长期结果的数据是在数量有限的观察病例中报道的,并且已经证明胃食管反流在胸腔镜组中更常见(OR, 2.82;95% ci, 1.72;4.61;p < 0.0001)。结论:荟萃分析证明,与开腹手术相比,胸腔镜手术的术后并发症发生率几乎相当,但吻合口漏除外。然而,不可能忽视现代治疗EA方法的显著优势,其特点之一是手术干预后患者恢复更快。
{"title":"SYSTEMATIC BIBLIOGRAPHICAL REVIEW AND META-ANALYSIS OF THORACOSCOPIC VS. OPEN-SURGICAL TREATMENT OF ESOPHAGEAL ATRESIA","authors":"Y. Kozlov, S. Poloyan, A. A. Marchuk, A. Rozhanski, A. A. Byrgazov, K. Kovalkov, C. Ochirov, V. Kapuller, A. Narkevich","doi":"10.24110/0031-403x-2023-102-4-112-124","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-112-124","url":null,"abstract":"Thoracoscopic reconstruction of esophageal atresia (EA) has become a standard procedure in many surgical centers Worldwide. The existing bibliographical reviews and meta-analyses have failed to demonstrate any significant difference in the immediate outcome of mini-aggressive treatment of EA. Authors had performed this truly systematic review and meta-analysis searching for the new evidence and confirmation of success of thoracoscopy in the treatment of EA. Materials and methods used: the systematic bibliographical review was prepared in accordance with the PRISMA 2020 statement guidelines. Thus, the scientific publications starting 1990 were searched in three major databases as follows: MEDLINE, PubMed and eLIBRARY.RU. Results: the included studies were published between 2008 and 2022 representing a total of 1958 cases that included 1369 (69.92%) open-surgery interventions and 589 (30.08%) thoracoscopic ones. Authors have found no significant difference between thoracoscopy and thoracotomy excluding an increased risk for esophageal anastomotic leak in the open-surgery treatment group (OR, 0.68; 95% CI, 0.46; 0.99; p = 0.04). A meta-analysis demonstrated that the thoracoscopy group had shorter time spent on lung ventilation (MD, -1.83; 95% CI, -3.02; -0.63; p = 0.003), shorter period to start oral feeding (MD, -1.34; 95% CI, -2.13; -0.56; p = 0.0008) and shorter hospital stay (MD, -4.26; 95% CI, -7.03; -1.49; p = 0.003). The data on the long-term outcomes of both thoracoscopic and open-surgery interventions were reported in a limited - insufficient number of observed cases and had demonstrated that gastroesophageal reflux was more common in the thoracoscopy group (OR, 2.82; 95% CI, 1.72; 4.61; p < 0.0001). Conclusion: the meta-analysis had proved that, compared to open-surgery, thoracoscopy is associated with an almost comparable rate of postoperative complications coupled with the exception of anastomotic leaks. However, it is impossible to ignore the significant advantages of the modern method for treatment of EA which is characterized - among other things - by the more rapid recovery of patients after the surgical interventions.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88624594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH VERY-EARLY ONSET 常染色体显性多囊肾病,发病很早
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-177-186
M. Shumikhina, O. Chugunova, A. Gurevich
Both autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease may occur at any age starting infancy and up to adulthood. Manifestations of autosomal dominant polycystic kidney disease usually occur in adult patients with a risk of development of end-stage renal failure after the fifth decade of life. However, an increase in the number of pediatric cases of a very-early onset of the disease, in utero or during the first 18 months of life, had been registered recently, that were characterized by severe clinical manifestations which in tis turn had mimic the autosomal recessive polycystic kidney disease. The three infant cases of autosomal dominant polycystic kidney disease are observed in the Article with perinatal period features, clinical manifestations of the disease, tests’ results and its interpretation given. Children with very-early onset of autosomal dominant polycystic kidney disease are in the high-risk group for nephromegaly, severe hypertension and the early end-stage renal failure.
常染色体显性多囊肾病和常染色体隐性多囊肾病都可能发生在从婴儿期到成年期的任何年龄。常染色体显性多囊肾病的表现通常发生在成年患者,在生命的第五个十年后有发展为终末期肾衰竭的风险。然而,最近登记的儿童病例中,在子宫内或出生后18个月内发病的病例数量有所增加,这些病例的特点是严重的临床表现,而这又类似于常染色体隐性多囊肾病。本文观察了3例婴儿常染色体显性多囊肾病的围生期特征、临床表现、检查结果及解释。早发常染色体显性多囊肾病患儿是肾病、重度高血压和早期终末期肾功能衰竭的高危人群。
{"title":"AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH VERY-EARLY ONSET","authors":"M. Shumikhina, O. Chugunova, A. Gurevich","doi":"10.24110/0031-403x-2023-102-4-177-186","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-177-186","url":null,"abstract":"Both autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease may occur at any age starting infancy and up to adulthood. Manifestations of autosomal dominant polycystic kidney disease usually occur in adult patients with a risk of development of end-stage renal failure after the fifth decade of life. However, an increase in the number of pediatric cases of a very-early onset of the disease, in utero or during the first 18 months of life, had been registered recently, that were characterized by severe clinical manifestations which in tis turn had mimic the autosomal recessive polycystic kidney disease. The three infant cases of autosomal dominant polycystic kidney disease are observed in the Article with perinatal period features, clinical manifestations of the disease, tests’ results and its interpretation given. Children with very-early onset of autosomal dominant polycystic kidney disease are in the high-risk group for nephromegaly, severe hypertension and the early end-stage renal failure.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77115660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
«DIAGNOSIS AND TREATMENT OF FABRY DISEASE: PROSPECTS AND CHALLENGES.» RESOLUTION BY THE COUNCIL OF EXPERTS DATED APRIL 20, 2023. MOSCOW, RUSSIA 法布里病的诊断与治疗:前景与挑战。*专家委员会2023年4月20日的决议。莫斯科,俄罗斯
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-172-176
E. Vasichkina, N. Vashakmadze, S. Voronin, E. Zakharova, A. Koroteev, E. Krasilnikova, S. Kutsev, S. V. Moiseev, T. Pervunina, A. G. Rumyantsev, E. Serebryakova, E.A. Khvostikova
For citation: E.S. Vasichkina, N.D. Vashakmadze, S.V. Voronin, E.Yu. Zakharova, A.L. Koroteev, E.Yu. Krasilnikova, S.I. Kutsev, S.V. Moiseev, T.M. Pervunina, A.G. Rumyantsev, E.A. Serebryakova, E.A. Khvostikova. «Diagnosis and treatment of Fabry disease: prospects and challenges.» Resolution by the Council of Experts dated April 20, 2023. Moscow, Russia. Pediatria n.a. G.N. Speransky. 2023; 102 (4): 172-176. DOI: 10.24110/0031-403X-2023-102-4-172-176.
{"title":"«DIAGNOSIS AND TREATMENT OF FABRY DISEASE: PROSPECTS AND CHALLENGES.» RESOLUTION BY THE COUNCIL OF EXPERTS DATED APRIL 20, 2023. MOSCOW, RUSSIA","authors":"E. Vasichkina, N. Vashakmadze, S. Voronin, E. Zakharova, A. Koroteev, E. Krasilnikova, S. Kutsev, S. V. Moiseev, T. Pervunina, A. G. Rumyantsev, E. Serebryakova, E.A. Khvostikova","doi":"10.24110/0031-403x-2023-102-4-172-176","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-172-176","url":null,"abstract":"For citation: E.S. Vasichkina, N.D. Vashakmadze, S.V. Voronin, E.Yu. Zakharova, A.L. Koroteev, E.Yu. Krasilnikova, S.I. Kutsev, S.V. Moiseev, T.M. Pervunina, A.G. Rumyantsev, E.A. Serebryakova, E.A. Khvostikova. «Diagnosis and treatment of Fabry disease: prospects and challenges.» Resolution by the Council of Experts dated April 20, 2023. Moscow, Russia. Pediatria n.a. G.N. Speransky. 2023; 102 (4): 172-176. DOI: 10.24110/0031-403X-2023-102-4-172-176.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75823886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
URINARY TRACT INFECTIONS IN PRETERM INFANTS: DIFFICULTIES IN DIAGNOSIS AND TREATMENT 早产儿尿路感染:诊断和治疗的困难
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-92-100
A. Safina, O. Chugunova, S. Paunova, M. A. Daminova
Urinary tract infections are a common problem in premature newborns, but its diagnosis is of certain difficulties due to the non-specific clinical picture and laboratory parameters, which in its turn complicates timely treatment and can therefore lead to the development of unfavorable complications. The article provides a bibliographical review on the issue and discusses the modern approaches to the diagnosis and treatment of urinary tract infections in premature newborns.
尿路感染是早产新生儿的常见问题,但由于临床表现和实验室参数的不特异性,其诊断存在一定困难,从而使及时治疗复杂化,从而导致不良并发症的发生。本文就这一问题进行了文献综述,并讨论了早产儿尿路感染的现代诊断和治疗方法。
{"title":"URINARY TRACT INFECTIONS IN PRETERM INFANTS: DIFFICULTIES IN DIAGNOSIS AND TREATMENT","authors":"A. Safina, O. Chugunova, S. Paunova, M. A. Daminova","doi":"10.24110/0031-403x-2023-102-4-92-100","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-92-100","url":null,"abstract":"Urinary tract infections are a common problem in premature newborns, but its diagnosis is of certain difficulties due to the non-specific clinical picture and laboratory parameters, which in its turn complicates timely treatment and can therefore lead to the development of unfavorable complications. The article provides a bibliographical review on the issue and discusses the modern approaches to the diagnosis and treatment of urinary tract infections in premature newborns.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82525309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL AND MICROBIOLOGICAL EFFICACY OF THE TREATMENT OF DIFFICULT TEMPORARY TEETH ERUPTION IN CHILDREN 儿童难治性临时萌牙的临床及微生物学疗效观察
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-73-79
L. Kiselnikova, V. Tsarev, M. Podporin, F.M. Balafendieva
Eruption of temporary teeth in children is accompanied by a wide range of undesirable local and general manifestations and the changes in the oral cavity microbiocenosis. The purpose of this research was to evaluate the clinical and microbiological effectiveness of the use of topical drugs in the syndrome of difficult temporary teeth eruption in children. Materials and methods used: 120 children aged 5 months to 2 years old randomly distributed into 3 groups of 40 with difficulties in the eruption of temporary teeth. For the studied period of eight days all of the children have been receiving drugs to relieve unwanted symptoms in case of difficult eruption of temporary teeth: Dantinorm Baby by BOIRON, France, CALGEL Teething Gel by GlaxoSmithKline Pharmaceuticals, UK/Poland, and Viburgel by Biologische Heilmittel Heel GmbH, Germany. The dental status was carried out according to the PMA index; the state of the oral cavity microbiocenosis was assessed as well. Results: the gums’ PMA index after the course of Dantinorm Baby corresponded to mild degree of gingivitis, whilst both CALGEL Teething Gel and Viburgel had corresponded to the moderate degree. Against the background of the drug use the ratio between cariogenic and periodontopathogenic groups of the microbiota shifted towards the predominance of stabilizing species such as S. salivarius, S. sanguis, Corynebacterium spp. and Veillonella parvula in the group 1 versus the use of the drugs in the groups 2 and 3. Conclusions: clinical efficacy of the Dantinorm Baby drug in difficult temporary teeth eruption was higher, was accompanied by stabilization of oral microbiocenosis in children.
儿童临时牙的萌出伴随着各种不良的局部和全身表现以及口腔微生物病的改变。本研究的目的是评估使用外用药物治疗儿童难治性暂时萌牙综合征的临床和微生物学效果。采用的材料和方法:将120名5个月~ 2岁的临时牙出牙困难患儿随机分为3组,每组40人。在为期八天的研究期间,所有儿童都接受了药物治疗,以缓解临时牙齿难以长出时的不良症状:法国BOIRON公司的Dantinorm Baby,英国/波兰葛兰素史克制药公司的CALGEL出牙凝胶,以及德国Biologische Heilmittel Heel GmbH公司的Viburgel。根据PMA指数进行牙齿状况检查;同时评估口腔微生物病的情况。结果:丹丹诺宝宝疗程后牙龈PMA指数为轻度牙龈炎,CALGEL出牙凝胶和Viburgel均为中度牙龈炎。在药物使用的背景下,与使用药物的2组和3组相比,1组的龋齿菌群和牙周病菌群的比例转向了稳定菌群,如唾液链球菌、血链球菌、棒状杆菌和细小微孔菌。结论:丹丹诺婴儿药物治疗难治性暂时萌牙的临床疗效较高,并伴有口腔微生物病的稳定。
{"title":"CLINICAL AND MICROBIOLOGICAL EFFICACY OF THE TREATMENT OF DIFFICULT TEMPORARY TEETH ERUPTION IN CHILDREN","authors":"L. Kiselnikova, V. Tsarev, M. Podporin, F.M. Balafendieva","doi":"10.24110/0031-403x-2023-102-4-73-79","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-73-79","url":null,"abstract":"Eruption of temporary teeth in children is accompanied by a wide range of undesirable local and general manifestations and the changes in the oral cavity microbiocenosis. The purpose of this research was to evaluate the clinical and microbiological effectiveness of the use of topical drugs in the syndrome of difficult temporary teeth eruption in children. Materials and methods used: 120 children aged 5 months to 2 years old randomly distributed into 3 groups of 40 with difficulties in the eruption of temporary teeth. For the studied period of eight days all of the children have been receiving drugs to relieve unwanted symptoms in case of difficult eruption of temporary teeth: Dantinorm Baby by BOIRON, France, CALGEL Teething Gel by GlaxoSmithKline Pharmaceuticals, UK/Poland, and Viburgel by Biologische Heilmittel Heel GmbH, Germany. The dental status was carried out according to the PMA index; the state of the oral cavity microbiocenosis was assessed as well. Results: the gums’ PMA index after the course of Dantinorm Baby corresponded to mild degree of gingivitis, whilst both CALGEL Teething Gel and Viburgel had corresponded to the moderate degree. Against the background of the drug use the ratio between cariogenic and periodontopathogenic groups of the microbiota shifted towards the predominance of stabilizing species such as S. salivarius, S. sanguis, Corynebacterium spp. and Veillonella parvula in the group 1 versus the use of the drugs in the groups 2 and 3. Conclusions: clinical efficacy of the Dantinorm Baby drug in difficult temporary teeth eruption was higher, was accompanied by stabilization of oral microbiocenosis in children.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72799518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RISK FACTORS FOR POOR NEPHROLOGICAL PROGNOSIS IN BOYS WITH X-LINKED ALPORT SYNDROME: A SINGLE CENTER COHORT STUDY x连锁alport综合征男孩肾病预后不良的危险因素:单中心队列研究
Q4 Medicine Pub Date : 2023-08-10 DOI: 10.24110/0031-403x-2023-102-4-52-58
M. Aksenova, N. Konkova, O. Piruzeeva, N. Zaikova, T. Lepaeva, T. Nikishina, V. Obukhova, V. Dlin
Males with X-linked Alport syndrome (XLAS) have a poor prognosis with a risk of developing kidney failure at a young age. Renal survival in glomerulopathies is determined by genetic and non-genetic risk factors with the role of the latter in Alport syndrome not being studied enough as yet. The purpose of this research was to determine the risk factors for poor nephrological prognosis in boys with XLAS. Materials and methods used: 89 boys aged 3 to 14 y/o with XLAS were included in a single-center cohort retrospective study. Blood pressure (BP), proteinuria (Pr, mg/m2/day), estimated glomerular filtration rate according to Bedside Schwartz Formula (eGFR, ml/min/1.73 m2 with norm≥90 ml/min/1.73 m2) and the data on therapy with angiotensin-converting enzyme inhibitors (ACEI) were monitored one time per 6 to 12 months for 4 [3; 6] years. BP≥90% was defined as uncontrolled (UHBP); proteinuria criterion Pr>100 mg/m2/day; the research endpoint was the time to reach eGFR<60 ml/min/1.73 m2. Results: 69 children had eGFR≥60 ml/min/1.73 m2 in dynamics (Group 1), 20 had reached the endpoint (Group 2). Age at inclusion, incidence of non-missense COL4A5 variants, birth weight, incidence of low body weight for gestational age, gross hematuria and age at onset of hematuria were not statistically significantly different between groups; UHBP (0.2 for G1 vs. 0.65 for G2; p<0.001), Pr (0.61 vs. 0.95, respectively; p=0.004), decrease in eGFR (0.06 vs. 0.45; p<0.001) were statistically significantly more common in G2. Boys from G2 were less likely to receive ACEI therapy (0.97 vs. 0.65; p=0.012); age of onset and doses of ACEI for ramipril were not statistically significantly different between the groups. Non-missense variants of COL4A5 (p=0.007), NBP (p<0.001), persistence of Pr>250 mg/m2/day (p<0.001), no ACEI therapy (p<0.001) and its onset at the stage of proteinuria (p<0.001) were the risk factors for reaching the endpoint. Persistence of Pr, UHBP, initiation of ACEI therapy at the proteinuria stage independently affected the progression of the disease. Conclusion: UHBP, proteinuria, lack of therapy/appointment of ACEI at the proteinuria stage of the disease are the risk factors for further poor nephrological prognosis in boys with XLAS.
患有x连锁Alport综合征(XLAS)的男性预后较差,在年轻时有发生肾衰竭的风险。肾小球疾病的肾脏生存是由遗传和非遗传危险因素决定的,而后者在Alport综合征中的作用尚未得到足够的研究。本研究的目的是确定XLAS男孩肾病预后不良的危险因素。使用的材料和方法:89名3 - 14岁的XLAS男孩纳入单中心队列回顾性研究。血压(BP)、蛋白尿(Pr, mg/m2/天)、根据床边施瓦茨公式估计的肾小球滤过率(eGFR, ml/min/1.73 m2,标准值≥90 ml/min/1.73 m2)和血管紧张素转换酶抑制剂(ACEI)治疗的数据每6至12个月监测一次,持续4年[3];6)年。血压≥90%定义为未控制(UHBP);蛋白尿标准Pr> 100mg /m2/day;研究终点为达到egfr250mg /m2/天的时间(p<0.001),未接受ACEI治疗(p<0.001)和ACEI在蛋白尿期发作(p<0.001)是达到终点的危险因素。持续的Pr, UHBP,在蛋白尿期开始ACEI治疗独立影响疾病的进展。结论:超高血压、蛋白尿、蛋白尿期缺乏ACEI治疗/预约是导致XLAS男童肾病预后进一步恶化的危险因素。
{"title":"RISK FACTORS FOR POOR NEPHROLOGICAL PROGNOSIS IN BOYS WITH X-LINKED ALPORT SYNDROME: A SINGLE CENTER COHORT STUDY","authors":"M. Aksenova, N. Konkova, O. Piruzeeva, N. Zaikova, T. Lepaeva, T. Nikishina, V. Obukhova, V. Dlin","doi":"10.24110/0031-403x-2023-102-4-52-58","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-4-52-58","url":null,"abstract":"Males with X-linked Alport syndrome (XLAS) have a poor prognosis with a risk of developing kidney failure at a young age. Renal survival in glomerulopathies is determined by genetic and non-genetic risk factors with the role of the latter in Alport syndrome not being studied enough as yet. The purpose of this research was to determine the risk factors for poor nephrological prognosis in boys with XLAS. Materials and methods used: 89 boys aged 3 to 14 y/o with XLAS were included in a single-center cohort retrospective study. Blood pressure (BP), proteinuria (Pr, mg/m2/day), estimated glomerular filtration rate according to Bedside Schwartz Formula (eGFR, ml/min/1.73 m2 with norm≥90 ml/min/1.73 m2) and the data on therapy with angiotensin-converting enzyme inhibitors (ACEI) were monitored one time per 6 to 12 months for 4 [3; 6] years. BP≥90% was defined as uncontrolled (UHBP); proteinuria criterion Pr>100 mg/m2/day; the research endpoint was the time to reach eGFR<60 ml/min/1.73 m2. Results: 69 children had eGFR≥60 ml/min/1.73 m2 in dynamics (Group 1), 20 had reached the endpoint (Group 2). Age at inclusion, incidence of non-missense COL4A5 variants, birth weight, incidence of low body weight for gestational age, gross hematuria and age at onset of hematuria were not statistically significantly different between groups; UHBP (0.2 for G1 vs. 0.65 for G2; p<0.001), Pr (0.61 vs. 0.95, respectively; p=0.004), decrease in eGFR (0.06 vs. 0.45; p<0.001) were statistically significantly more common in G2. Boys from G2 were less likely to receive ACEI therapy (0.97 vs. 0.65; p=0.012); age of onset and doses of ACEI for ramipril were not statistically significantly different between the groups. Non-missense variants of COL4A5 (p=0.007), NBP (p<0.001), persistence of Pr>250 mg/m2/day (p<0.001), no ACEI therapy (p<0.001) and its onset at the stage of proteinuria (p<0.001) were the risk factors for reaching the endpoint. Persistence of Pr, UHBP, initiation of ACEI therapy at the proteinuria stage independently affected the progression of the disease. Conclusion: UHBP, proteinuria, lack of therapy/appointment of ACEI at the proteinuria stage of the disease are the risk factors for further poor nephrological prognosis in boys with XLAS.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90976240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OSTEOSARCOMA AND EWING’S SARCOMA OF THE MAXILLOFACIAL REGION IN CHILDREN: THERAPEUTIC APPROACHES AND SURGICAL LOCAL CONTROL FEATURES 儿童颌面骨肉瘤和尤文氏肉瘤:治疗方法和手术局部控制特征
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.24110/0031-403x-2023-102-3-131-136
E.I. Chechev, N. S. Grachev, N. V. Babaskina, I. N. Vorozhtsov, E. Konopleva
Authors analyze bibliographical data on the treatment of osteosarcoma and Ewing's sarcoma of the maxillofacial region in children and adolescents. The role of surgical treatment in the primary lesion of this localization is analyzed in detail as well as the complex therapeutic approaches.
作者分析了儿童和青少年颌面骨肉瘤和尤文氏肉瘤治疗的文献资料。详细分析了手术治疗在原发性病变中的作用以及复杂的治疗方法。
{"title":"OSTEOSARCOMA AND EWING’S SARCOMA OF THE MAXILLOFACIAL REGION IN CHILDREN: THERAPEUTIC APPROACHES AND SURGICAL LOCAL CONTROL FEATURES","authors":"E.I. Chechev, N. S. Grachev, N. V. Babaskina, I. N. Vorozhtsov, E. Konopleva","doi":"10.24110/0031-403x-2023-102-3-131-136","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-3-131-136","url":null,"abstract":"Authors analyze bibliographical data on the treatment of osteosarcoma and Ewing's sarcoma of the maxillofacial region in children and adolescents. The role of surgical treatment in the primary lesion of this localization is analyzed in detail as well as the complex therapeutic approaches.","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79201988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SURROGATE BIOMARKERS OF INSULIN RESISTANCE IN OBESE CHILDREN AND ADOLESCENTS 肥胖儿童和青少年胰岛素抵抗的替代生物标志物
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.24110/0031-403x-2023-102-3-174-182
Y. Samoilova, M. Kovarenko, O. Oleynik, D. Kudlay, M. Matveeva, D. Podchinenova, I. Novikova, S. Romanenko
Obesity is the most common reason for the insulin resistance (IR) though obesity in children is not always associated with IR. The markers based on fasting glucose and/or insulin levels and alternative parameters with conventional lipid-based indexes are used in assessing the IR in clinical practice. The purpose of the research was to assess the relationship between alternative IR surrogate biomarkers as follows: triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C), TG/HDL-C ratio; single-point insulin sensitivity estimator (SPISE) index; triglyceride-glucose index (TyG), with generally accepted indices based on the insulin/glucose ratios, such as HOMA-IR, QUICKI, Caro, in a cohort of obese children and adolescents. Materials and methods used: a single-stage multicenter comparative study was conducted involving 127 patients aged 6 to 17 y/o with simple obesity of varying degrees. The following indices were calculated: HOMA-IR = fasting insulin (mU/ml) x fasting plasma glucose (FPG) (mmol/L) / 22.5; QUICKI = 1/Log (Fasting Insulin, µU/ml) + Log (Fasting Glucose, mg/dl); Caro = fasting plasma glucose (mmol/l) / fasting insulin (μU/ml); TG/HDL-C = TG (mmol/L) / HDL-C (mmol/L); triglyceride-glucose index TyG = Ln [fasting TG (mg/dl) x fasting plasma glucose (mg/dl)/2], where Ln is the logarithm; SPISE = 600 × HDL-C0.185/(TG0.2 x BMI1.338). Results: 75 (59%) boys and 52 (41%) girls were included in the study; the median age was 12.9 [10.4; 14.9] y/o. Pre-pubertal development was recorded in 25 (19.7%), pubertal - in 102 (80.3%). The prevalence of impaired glucose tolerance (IGT) was 5.5%. In children with IGT, the SPISE index was lower than in children with normal glucose tolerance (3.69 [3.49; 4.37] vs. 4.8 [3.99; 5.55], p=0.021) with no statistically significant differences between these groups in other markers. In the IGT subgroup, a high negative correlation was found between SDS BMI and SPISE (R=-0.97). In the general SDS group, BMI correlated with insulin (R=+0.24), TG (R=+0.2), HOMA (R=+0.24), Caro (R=-0.26), TG/HDL-C (R=+0.28) and SPISE (R=-0.65). The SPISE index was lower in girls than in boys (4.94 [3.63; 5.73] vs. 4.07 [3.59; 5.16], p = 0.045). No statistically significant differences were recorded for other gender-related markers. A negative correlation was also found between the obesity degree and SPISE in the subgroups of girls (R=-0.49) and boys (R=-0.70) as well as among pre-pubertal children of both genders (R=-0.61). The maximum correlation between SDS BMI and SPISE was recorded in the subgroup of teenagers of both genders (R=-0.88). In the general group, TyG was weakly correlated with HOMA-IR (R=+0.26) and QUICKI (R=-0.24), while SPISE showed a weak association with all studied insulin indices; no statistically significant correlation between insulin indices and TG/HDL-C was found. In the subgroup of girls, no significant relationships between the evaluated markers were found, in the subgroup of boys, TyG weakly correl
肥胖是胰岛素抵抗(IR)最常见的原因,但儿童肥胖并不总是与IR相关。在临床实践中,基于空腹血糖和/或胰岛素水平的标记物和传统的基于脂质的指标的替代参数用于评估IR。本研究的目的是评估以下替代IR生物标志物之间的关系:甘油三酯(TG)与高密度脂蛋白胆固醇(HDL-C), TG/HDL-C比率;单点胰岛素敏感性估计指数;甘油三酯-葡萄糖指数(TyG),与普遍接受的基于胰岛素/葡萄糖比率的指标,如HOMA-IR, QUICKI, Caro,在肥胖儿童和青少年队列中。材料与方法:采用单阶段多中心比较研究,纳入127例6 ~ 17岁不同程度单纯性肥胖患者。计算以下指标:HOMA-IR =空腹胰岛素(mU/ml) ×空腹血糖(FPG) (mmol/L) / 22.5;QUICKI = 1/Log(空腹胰岛素,µU/ml) + Log(空腹血糖,mg/dl);Caro =空腹血糖(mmol/l) /空腹胰岛素(μU/ml);TG/HDL-C = TG (mmol/L) /HDL-C (mmol/L);甘油三酯-葡萄糖指数TyG = Ln[空腹TG (mg/dl) ×空腹血浆葡萄糖(mg/dl)/2],其中Ln为对数;SPISE = 600 × HDL-C0.185/(TG0.2 × BMI1.338)。结果:75名(59%)男孩和52名(41%)女孩被纳入研究;中位年龄为12.9岁[10.4;14.9] y / o。青春期前发育25例(19.7%),青春期发育102例(80.3%)。糖耐量受损(IGT)患病率为5.5%。IGT患儿的SPISE指数低于糖耐量正常患儿(3.69 [3.49;4.37] vs. 4.8 [3.99;5.55], p=0.021),其他指标组间差异无统计学意义。在IGT亚组中,SDS BMI与SPISE呈高度负相关(R=-0.97)。在一般SDS组中,BMI与胰岛素(R=+0.24)、TG (R=+0.2)、HOMA (R=+0.24)、Caro (R=-0.26)、TG/HDL-C (R=+0.28)和SPISE (R=-0.65)相关。SPISE指数女生低于男生(4.94;3.63;5.73 vs. 4.07 [3.59;5.16], p = 0.045)。其他与性别相关的标记没有统计学上的显著差异。肥胖程度与SPISE在女孩亚组(R=-0.49)和男孩亚组(R=-0.70)以及青春期前儿童(R=-0.61)之间均呈负相关。SDS - BMI与SPISE的相关性在男女青少年亚组中均最高(R=-0.88)。在普通组中,TyG与HOMA-IR (R=+0.26)和QUICKI (R=-0.24)呈弱相关,而SPISE与所有胰岛素指标呈弱相关;胰岛素指数与TG/HDL-C之间无统计学意义相关。在女孩亚组中,TyG与HOMA-IR (R=+0.29)和QUICKI (R=-0.32)呈弱相关(R=+0.29)。在男孩中,SPISE与所有研究的胰岛素指数之间有较强的相关性。在青春期前患者亚组中,TyG与QUICKI (R=-0.44)、SPISE与Caro (R=+0.56)、SPISE与HOMA-IR (R=-0.50)存在相关性。TG/HDL-C比值与传统IR标志物无统计学显著相关。在普通组和男孩亚组中,TyG与HOMA-IR和QUICKI呈弱相关。青春期前期,TyG仅与QUICKI呈弱相关,与青春期儿童胰岛素基础指标无明显相关性。SPISE指数在主组和单个亚组中均与胰岛素标志物相关。结论:SPISE指数可被认为是评估肥胖儿童和青少年IR的一种相对简单易行的方法。
{"title":"SURROGATE BIOMARKERS OF INSULIN RESISTANCE IN OBESE CHILDREN AND ADOLESCENTS","authors":"Y. Samoilova, M. Kovarenko, O. Oleynik, D. Kudlay, M. Matveeva, D. Podchinenova, I. Novikova, S. Romanenko","doi":"10.24110/0031-403x-2023-102-3-174-182","DOIUrl":"https://doi.org/10.24110/0031-403x-2023-102-3-174-182","url":null,"abstract":"Obesity is the most common reason for the insulin resistance (IR) though obesity in children is not always associated with IR. The markers based on fasting glucose and/or insulin levels and alternative parameters with conventional lipid-based indexes are used in assessing the IR in clinical practice. The purpose of the research was to assess the relationship between alternative IR surrogate biomarkers as follows: triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C), TG/HDL-C ratio; single-point insulin sensitivity estimator (SPISE) index; triglyceride-glucose index (TyG), with generally accepted indices based on the insulin/glucose ratios, such as HOMA-IR, QUICKI, Caro, in a cohort of obese children and adolescents. Materials and methods used: a single-stage multicenter comparative study was conducted involving 127 patients aged 6 to 17 y/o with simple obesity of varying degrees. The following indices were calculated: HOMA-IR = fasting insulin (mU/ml) x fasting plasma glucose (FPG) (mmol/L) / 22.5; QUICKI = 1/Log (Fasting Insulin, µU/ml) + Log (Fasting Glucose, mg/dl); Caro = fasting plasma glucose (mmol/l) / fasting insulin (μU/ml); TG/HDL-C = TG (mmol/L) / HDL-C (mmol/L); triglyceride-glucose index TyG = Ln [fasting TG (mg/dl) x fasting plasma glucose (mg/dl)/2], where Ln is the logarithm; SPISE = 600 × HDL-C0.185/(TG0.2 x BMI1.338). Results: 75 (59%) boys and 52 (41%) girls were included in the study; the median age was 12.9 [10.4; 14.9] y/o. Pre-pubertal development was recorded in 25 (19.7%), pubertal - in 102 (80.3%). The prevalence of impaired glucose tolerance (IGT) was 5.5%. In children with IGT, the SPISE index was lower than in children with normal glucose tolerance (3.69 [3.49; 4.37] vs. 4.8 [3.99; 5.55], p=0.021) with no statistically significant differences between these groups in other markers. In the IGT subgroup, a high negative correlation was found between SDS BMI and SPISE (R=-0.97). In the general SDS group, BMI correlated with insulin (R=+0.24), TG (R=+0.2), HOMA (R=+0.24), Caro (R=-0.26), TG/HDL-C (R=+0.28) and SPISE (R=-0.65). The SPISE index was lower in girls than in boys (4.94 [3.63; 5.73] vs. 4.07 [3.59; 5.16], p = 0.045). No statistically significant differences were recorded for other gender-related markers. A negative correlation was also found between the obesity degree and SPISE in the subgroups of girls (R=-0.49) and boys (R=-0.70) as well as among pre-pubertal children of both genders (R=-0.61). The maximum correlation between SDS BMI and SPISE was recorded in the subgroup of teenagers of both genders (R=-0.88). In the general group, TyG was weakly correlated with HOMA-IR (R=+0.26) and QUICKI (R=-0.24), while SPISE showed a weak association with all studied insulin indices; no statistically significant correlation between insulin indices and TG/HDL-C was found. In the subgroup of girls, no significant relationships between the evaluated markers were found, in the subgroup of boys, TyG weakly correl","PeriodicalId":39654,"journal":{"name":"Pediatriya - Zhurnal im G.N. Speranskogo","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91213386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatriya - Zhurnal im G.N. Speranskogo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1